Drug Sponsors

Merck Serono: 40% of Geneva staff have job prospects

Tuesday, October 2, 2012 01:50 PM

Merck Serono has provided an update on the redeployment of its Geneva-based staff, 100 days after announcing its decision to close the site. As of Sept. 28, job prospects have been clarified for more than 500 employees, or 40% of Geneva-based employees:

More... »

Evotec, Bayer form multi-target alliance to fight endometriosis

Monday, October 1, 2012 02:57 PM

Evotec, a German drug discovery alliance and development partnership company, and Bayer have entered into a five-year, multi-target collaboration with the goal of developing three clinical candidates for the treatment of endometriosis.

More... »

Cardium acquires To Go Brands

Monday, October 1, 2012 10:24 AM

Cardium Therapeutics, an asset-based health sciences and regenerative medicine company based in San Diego, announced that its MedPodium operating unit has acquired the assets, business and product portfolio of San Diego-based To Go Brands, a developer of nutraceutical powder mixes, supplements and chews to support healthy lifestyles, to support the expansion of Cardium's health sciences nutraceutical brand platform.

More... »

NeuroCog Trials receives $1.2M NIMH grant

Monday, October 1, 2012 09:09 AM

NeuroCog Trials, a Durham, N.C.-based cognitive services provider for the clinical trials industry, has received a 2012 phase II grant from the Small Business Innovation Research (SBIR) program from the National Institute of Mental Health (NIMH), for the validation and commercialization of its Virtual Reality Functional Capacity Assessment Tool (VRFCAT).

More... »

Medtronic to acquire China Kanghui Holdings

Friday, September 28, 2012 02:32 PM

Medtronic, a global medical technology company based in Minneapolis, Minn., has agreed to acquire China Kanghui Holdings for approximately $816 million in cash ($30.75 per American depository share). The total value of the transaction, net of Kanghui's cash, is expected to be approximately $755 million.

More... »

Medicago, Philip Morris ink agreement for flu vaccines in China

Friday, September 28, 2012 11:11 AM

Medicago, a Canadian biopharmaceutical company focused on vaccines, has signed a licensing agreement with Philip Morris Products, a subsidiary of international tobacco company Philip Morris International.

More... »

InVivo opens new office and labs in Cambridge, Mass.

Wednesday, September 26, 2012 10:47 AM

InVivo Therapeutics Holdings (NVIV), a developer of technologies for the treatment of spinal cord injuries and neurotrauma, has opened the company’s new office, manufacturing and lab space at in Cambridge, Mass. Consolidating all of InVivo’s operations, the 21,000 square foot facility will serve as the new headquarters for the company.

More... »

SGS’s N.J. facility undergoes major expansion

Tuesday, September 25, 2012 03:44 PM

SGS Life Science Services has reopened its Fairfield, N.J. facility, having just completed a major renovation that involved doubling the size of facility, investing in new, increased laboratory space, expanded client accommodation and new equipment.

More... »

GenVec cuts workforce by 30%

Tuesday, September 25, 2012 01:52 PM

GenVec, a biopharmaceutical company based in Gaithersburg, Md., is lowering its operating costs to conserve capital including eliminating 23 positions, or approximately 30% of its workforce.

More... »

EMD Millipore opens GMP bioproduction facility in France

Tuesday, September 25, 2012 12:02 PM

EMD Millipore, the Billerica, Mass.-based life science division of Merck, has opened its advanced GMP bioproduction facility in Martillac, France, offering a full, single-use process train to speed a molecule’s journey to the clinic.

More... »